Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Total Neoadjuvant Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05858567
What this trial is testing

Total Neoadjuvant Therapy With Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Ultra Low Rectal Adenocarcinoma

Who this might be right for
Rectal Cancer
Sir Run Run Shaw Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07314528
What this trial is testing

Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer

Who this might be right for
Rectal Cancer PatientsObesity &Amp; OverweightLocally Advanced Rectal Cancer (LARC)+2 more
St. James's Hospital, Ireland 42
Testing effectiveness (Phase 2)Study completedNCT02921256
What this trial is testing

Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer

Who this might be right for
Rectal AdenocarcinomaStage II Rectal Cancer AJCC v7Stage III Rectal Cancer AJCC v7
National Cancer Institute (NCI) 363
Testing effectiveness (Phase 2)Looking for participantsNCT05254327
What this trial is testing

Trial of the Efficacy and Safety of Short and Long Course Radiation Therapy With/Without BMX-001

Who this might be right for
Rectal Cancer
University of Nebraska 118
Testing effectiveness (Phase 2)Study completedNCT03565029
What this trial is testing

Total Neoadjuvant Treatment Without Surgery For Locally Advanced Rectal Cancer

Who this might be right for
Colo-rectal Cancer
Niguarda Hospital 180
Post-approval studies (Phase 4)UnknownNCT04747951
What this trial is testing

Total Neoadjuvant Therapy in Rectal Cancer Treatment

Who this might be right for
Rectal Cancer
State Scientific Centre of Coloproctology, Russian Federation 280
Testing effectiveness (Phase 2)UnknownNCT02488707
What this trial is testing

Minimally Invasive Sphincter Sparing Total Mesorectal Excision for Ultra-low Rectal Cancer After Initial Chemo-radiotherapy (MISS-TRICR).

Who this might be right for
Rectal Cancer
Mansoura University 250
Large-scale testing (Phase 3)Not Yet RecruitingNCT06980545
What this trial is testing

Total Neoadjuvant 6 Cycles of Chemotherapy Versus 3 Cycles in Partial Responder Patients Diagnosed With Epithelial Ovarian Cancer

Who this might be right for
Stage III and IV Ovarian Cancer
Assiut University 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT05856305
What this trial is testing

SCRT in TNT With or Without Chlorophyllin

Who this might be right for
Rectal Neoplasms
Tata Memorial Centre 76
Large-scale testing (Phase 3)Not Yet RecruitingNCT07277842
What this trial is testing

PD-1 + FOLFOXIRI vs CAPOX as Total Neoadjuvant Therapy for pMMR Low Rectal Cancer

Who this might be right for
Locally Advanced Low Rectal AdenocarcinomapMMR (Microsatellite Stable Rectal Cancer)
Sun Yat-sen University 382
Testing effectiveness (Phase 2)UnknownNCT05845268
What this trial is testing

Total Neoadjuvant Therapy Combined With Tislelizumab for Local Advanced of Middle and Low Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Beijing Friendship Hospital 102
Not applicableLooking for participantsNCT07108348
What this trial is testing

ADAR1 Expression Level in Rectal Cancer

Who this might be right for
Rectum Cancer, Adenocarcinoma
Necmettin Erbakan University 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05998122
What this trial is testing

Total Neoadjuvant Chemoradiotherapy Plus Anti-PD-1 in Subperitoneal Patients With Locally Advanced Rectal CancerPatients With Locally Advanced Rectal Cancer: A Prospective, Single Arm, Exploratory Study

Who this might be right for
Locally Advanced Rectal CancerTotal Neoadjuvant TreatmentAnti-PD-1
The First Hospital of Jilin University 45
Large-scale testing (Phase 3)Not Yet RecruitingNCT06861777
What this trial is testing

Total Neoadjuvant Therapy Combined With Adebrelimab in Locally Advanced Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
YIN LI 474
Testing effectiveness (Phase 2)Looking for participantsNCT07448142
What this trial is testing

Low-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal Cancer

Who this might be right for
Colorectal Cancer (CRC)
Sun Yat-sen University 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06390982
What this trial is testing

Organ Preservation With Tislelizumab and Total Neoadjuvant Therapy in Patients With Low Rectal Cancer: RELIEVE -01 Study

Who this might be right for
RECTAL NEOPLASMSRectal Cancer
Fudan University 46
Not applicableLooking for participantsNCT05883800
What this trial is testing

Total Neoadjuvant Treatment Combined With Adaptive Radiotherapy for Rectal Cancer

Who this might be right for
Rectal Cancer
Haukeland University Hospital 61
Large-scale testing (Phase 3)Not Yet RecruitingNCT07118800
What this trial is testing

Study Evaluating Two Treatment Strategies for Rectal Cancer in Patients ≥75 Years Old

Who this might be right for
Locally Advanced Rectal Adenocarcinoma
UNICANCER 160
Not applicableNot Yet RecruitingNCT07557316
What this trial is testing

Nodal Downstaging Versus Primary Tumor Regression as Predictors of Survival After Total Neoadjuvant Therapy for Rectal Cancer: A Retrospective Study

Who this might be right for
Rectal Cancer PatientsTotal Neoadjuvant Therapy
Sohag University 100
Not applicableLooking for participantsNCT06052332
What this trial is testing

Efficacy and Safety of Conventional Neoadjuvant Therapy Versus Total Neoadjuvant Therapy in Older Patients With Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal CancerOlder People
Jules Bordet Institute 230
Next Page